At The Crossroads, Part 2: Finding Hep C Infections Before It's Too Late
Hepatitis C infects an estimated five million Americans, nearly 20-thousand Rhode Islanders among them. And most of them don’t know it. But many are...
View ArticleAt The Crossroads, Part 3: As Old Hepatitis C Treatment Fades Out, New...
In just a few weeks, another pharmaceutical company will likely win FDA approval for a new drug to cure hepatitis C. That makes three breakthrough...
View ArticleAt The Crossroads, Part 4: New Hep C Drugs Promise A Cure, For A Big Price
This year marks the 25th anniversary of the discovery of the hepatitis C virus. Since then, people with hepatitis C have had limited – and not very...
View ArticleAt The Crossroads, Part 5: The Uncomfortable Math Of Hep C Treatment
What’s the price of a human life? Many of us would say each life is priceless. But health economists sometimes have a number in mind. Want to know what...
View ArticleAt The Crossroads, Part 6: Veterans Harder Hit By Hep C
In our ongoing series about hepatitis C, we look now at one of the hardest hit populations: veterans. Hep C is three times more prevalent among vets...
View ArticleAt The Crossroads, Part 7: Behind Bars, Hep C Takes A Toll On Inmates, And...
Rhode Island’s prisons are grappling with a dilemma. Hundreds of inmates have hepatitis C. New drugs can cure it. But they’re so expensive the...
View ArticleAt The Crossroads, Part 8: Fueled By Opioid Abuse, New Hep C Infections Rise
In 2014, hundreds of Rhode Islanders died from accidental drug overdoses. Thousands more remain addicted to prescription painkillers and heroin. For...
View ArticleAt The Crossroads: One-Hour Special
We're wrapping up our months-long series about one of the greatest public health challenges facing Rhode Island: hepatitis C. Listen online or download...
View Article
